Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine

Drug and Alcohol Dependence

Volumn 67, Issue 1, 2002, Pages 73-79

  Ross, Brian M ^a   Moszczynska, Anna ^a   Peretti, Frank J ^b   Adams, Vernard ^c   Schmunk, Gregory A ^d   Kalasinsky, Kathryn S ^e   Ang, Lee ^f   Mamalias, Nikolaos ^a   Turenne, Sylvie D ^a   Kish, Stephen J ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b Arkansas State Crime Laboratory   (United States)

^c Hillsborough Co Med Examiner Dept   (United States)

^d Santa Clara County Medical Examiner Coroner   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Addiction; CDP choline; Cocaine; Dopamine; Methamphetamine; Phospholipase A2

Indexed keywords

CALCIUM; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; COCAINE; METHAMPHETAMINE; PHOSPHOLIPASE A2;

ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PUTAMEN; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; BRAIN MAPPING; CALCIUM; CEREBELLAR CORTEX; CEREBRAL CORTEX; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; DOPAMINE; DOWN-REGULATION; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PUTAMEN;

EID: 18444396153     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00022-4     Document Type: Article

References (26)

1. Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease
2. 2 in dopamine-1 receptor mediated cellular signaling mechanisms in the proximal tubules of SHR
3. The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward-seeking
4. Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter
5. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathophysiologic and clinical implications
6. Effects of orally administered cytidine 5′-diphosphate choline on brain phospholipid content
7. Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers
8. Activation of soluble striatal tyrosine hydroxylase in the rat brain after CDP choline administration
9. 2(s); Comparison of arachidonyl-selective and -nonselective enzymes
10. 2 dopamine receptor expressed in CHO cells
11. Indomethacin potentiates the operant behavior suppressant and rectal temperature lowering effects of low doses of d-amphetamine in rats
12. 2-receptor-mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2+-mobilizing agent
13. 2 mechanisms in the development of stimulant sensitisation
14. Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: A preliminary report
15. Characterization of lysophospholipid metabolizing enzymes in human brain
16. Characterization of a novel phospholipase A2 activity in human brain
17. Multiple forms of the enzyme glycerophosphodiesterase are present in human brain
18. 2 activity is selectively decreased in the striatum of chronic cocaine users
19. Phospholipid biosynthetic enzymes in human brain
20. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: Possible implications for Parkinson's disease
21. CDP-choline: Pharmacological and clinical review
22. The eicosanoids: Cyclooxygenase, lipoxygenase, and epoxygenase pathways
23. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine
24. 2
25. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
26. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users